Mevion withdraws IPO plans; NuVasive settles with DOJ for $13.5M;

@FierceMedDev: FierceDiagnostics story: Foundation Medicine trips in Q2 with sluggish test reimbursement. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: NeuWave Medical gets FDA clearance for software upgrade to its ablation system. Report | Follow @VarunSaxena2

@EmilyWFierce: It's not a good week to be a drugmaker in Romania. More from FiercePharma | Follow @EmilyWFierce

> Proton radiation therapy system maker Mevion Medical Systems has withdrawn plans for an IPO. Its investors include Caxton Associates, ProQuest Investments, Venrock Healthcare Partners and CHL Medical Partners. More

> NuVasive ($NUVA) has settled with the U.S. Department of Justice over allegations of off-label promotions for $13.5 million. More

> GE Healthcare ($GE) and Ochsner Health System have partnered to back a competition to solicit ideas for novel wearable devices and mobile apps to address chronic disease patients. The Phase 1 winners get $1,000 and can move on to Phase 2 where up to 3 winners will get a total of $15,000 for development. The deadline is Sept. 15. More

> Sorin has launched its Reply CRT-P cardiac resynchronization pacemaker, which it says is the world's smallest. More

Biotech News

@FierceBiotech: ICYMI yesterday: Failed Alzheimer's drug wins $117M in vTv's IPO. Article | Follow @FierceBiotech

@JohnCFierce: 125 ex-$GSK R&D staffers in RTP face the ax--again (Great industry. Where else can you get fired twice in 8 months?) News | Follow @JohnCFierce

> Amgen lops another 10% off its R&D budget amid wide cost cuts. Story

> Merck's Ebola vaccine is 100% successful in interim Phase III results. News

> AstraZeneca isn't giving up on brodalumab despite its links to suicide. Article

Pharma News

@FiercePharma: IDEXX shares climb on record diagnostics placements and Q2 earnings gain. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: As Hospira expands recall of ketorolac to 37M vials you've got to wonder what Pfizer thinks. Story | Follow @EricPFierce

@CarlyHFierce: Celgene fights for sanction on patent challenger Bass. More | Follow @CarlyHFierce

> GSK hiring 130 at inhaler facility, even as CRO axes up to 200 GSK alum. Report

> Romania launches bribery probe into 11 drugmakers. Article

Suggested Articles

Millions of tests are urgently needed as the virus keeps communities across the country in lockdown and hospitals are overwhelmed with patients.

The FDA granted its first emergency authorization for a rapid antibody blood test for COVID-19 developed by Cellex.

The ultimate goal is to move as many patients as possible out of the clinic that don’t need immediate, critical care.